Beyond TSH: The Hidden Markers in Your Blood Test That Reveal Thyroid Dysfunction

By Rohan Smith | Functional Medicine Practitioner | Adelaide, South Australia

Quick Answer

Thyroid Stimulating Hormone (TSH) is commonly used to assess thyroid function, but it does not directly measure thyroid hormone availability or activity in the body. Many individuals with ongoing symptoms such as fatigue, weight gain, or brain fog may have “normal” TSH levels despite underlying thyroid dysfunction. Assessing additional markers — including Free T4, Free T3, Reverse T3, and thyroid antibodies — can provide a more complete picture of thyroid physiology and may help identify patterns associated with impaired hormone conversion, autoimmune thyroid disease, or altered hormone signalling (1–4).

Understanding TSH: The Basics of Thyroid Testing

TSH is a hormone produced by the pituitary gland that stimulates the thyroid gland to produce thyroxine (T4) and triiodothyronine (T3). In conventional practice, TSH is often used as the primary screening marker for thyroid dysfunction.

Elevated TSH levels are typically associated with hypothyroidism, while suppressed TSH levels may suggest hyperthyroidism. However, TSH reflects pituitary signalling rather than circulating or cellular thyroid hormone activity, which means it may not capture all clinically relevant thyroid imbalances (1,2).

Why TSH Alone Isn’t Enough

Although TSH is a useful regulatory marker, relying on it alone has recognised limitations. TSH does not assess:

• The amount of active thyroid hormone available to tissues
• Peripheral conversion of T4 into T3
• Autoimmune activity affecting the thyroid gland
• Functional interference with thyroid hormone signalling

As a result, some individuals experience persistent fatigue with normal blood tests, despite TSH values falling within reference ranges (3–5).

Key Thyroid Markers Often Overlooked

Free T4 and Free T3

Free T4 represents the circulating, inactive thyroid hormone available for conversion, while Free T3 is the biologically active hormone that regulates metabolic rate, mitochondrial function, and energy production.

Low Free T3 levels may be observed in individuals with chronic illness, inflammation, caloric restriction, or physiological stress. These patterns are often explored further through thyroid hormone conversion pathways, which influence how effectively T4 is converted into active T3 (6–8).

Reverse T3

Reverse T3 (rT3) is an inactive metabolite produced from T4. Under certain physiological conditions — such as illness, inflammation, or sustained stress — a greater proportion of T4 may be shunted toward Reverse T3 rather than active T3 (9,10).

In these cases, Reverse T3 may reflect adaptive or stress-related thyroid changes and is best interpreted alongside other markers and broader physiological stress patterns, rather than as a standalone indicator (9–11).

Thyroid Antibodies

Thyroid antibodies help identify autoimmune thyroid disease, the most common cause of hypothyroidism in iodine-sufficient regions. Common markers include anti-thyroid peroxidase (anti-TPO) antibodies and anti-thyroglobulin antibodies.

Elevated antibodies may be present years before overt thyroid hormone abnormalities develop and can be detected even when TSH remains within reference ranges (12–14).

The Role of Autoimmunity in Thyroid Dysfunction

Autoimmune thyroid diseases, such as Hashimoto’s thyroiditis and Graves’ disease, involve immune-mediated damage to thyroid tissue. In early or subclinical stages, individuals may have normal TSH and thyroid hormone levels despite ongoing immune activity and inflammation (12,13).

Identifying autoimmune patterns early may allow for monitoring and supportive strategies aimed at preserving thyroid function over time (14).

Case Illustration (Hypothetical Example)

A hypothetical example involves a woman in her mid-30s experiencing persistent fatigue, weight gain, and low mood despite repeated “normal” TSH results. Expanded thyroid testing revealed low Free T3 levels alongside elevated thyroid antibodies, suggesting autoimmune thyroid involvement with impaired hormone conversion.

This illustration highlights how broader testing can sometimes reveal patterns not evident on TSH alone, though individual results and responses vary and require clinical interpretation (6,12).

When to Consider Comprehensive Thyroid Testing

Additional markers may be considered when an individual experiences:

• Persistent fatigue, brain fog, or cold intolerance
• Unexplained weight changes
• Hair thinning or dry skin
• A family history of autoimmune disease
• Thyroid-related symptoms despite normal TSH results

In these situations, discussing comprehensive thyroid testing with a qualified practitioner may help clarify underlying patterns.

Key Insights

• TSH reflects pituitary signalling, not tissue-level thyroid activity
• Free T3 and Free T4 provide insight into hormone availability and conversion
• Reverse T3 may reflect adaptive responses to stress or illness
• Thyroid antibodies can identify autoimmune activity before overt dysfunction
• Pattern recognition across markers is more informative than isolated values

When “Normal” Isn’t Reassuring: Taking a Deeper Look at Thyroid Function

Being told your thyroid tests are “normal” can be frustrating when symptoms persist. Because thyroid function involves hormone production, conversion, immune activity, and tissue-level signalling, a single marker like TSH may not capture the full picture.

At Elemental Health & Nutrition, individuals in Adelaide are supported through a functional medicine approach that interprets thyroid markers in context — alongside symptoms, immune patterns, nutrient status, and stress physiology. A personalised assessment may help clarify whether hidden thyroid patterns are contributing to ongoing fatigue, weight changes, or cognitive symptoms, and guide appropriate next steps with greater confidence.

References

1. Spencer CA et al. Clinical review: Clinical utility of sensitive thyrotropin assays in thyroid diagnosis. Thyroid. 2010.
2. Hoermann R et al. Homeostatic control of the thyroid–pituitary axis: perspectives for diagnosis and treatment. Eur J Endocrinol. 2015.
3. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005.
4. Midgley JEM et al. Time for a reassessment of the treatment of hypothyroidism. Front Endocrinol. 2017.
5. Taylor PN et al. Thyroid hormones and health outcomes. BMJ. 2014.
6. Bianco AC et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002.
7. Peeters RP et al. Thyroid hormone metabolism in critical illness. J Clin Endocrinol Metab. 2005.
8. Fliers E et al. Thyroid function in critically ill patients. Nat Rev Endocrinol. 2014.
9. Chopra IJ. Euthyroid sick syndrome. J Clin Endocrinol Metab. 1997.
10. Peeters RP. Non-thyroidal illness: to treat or not to treat? Best Pract Res Clin Endocrinol Metab. 2001.
11. Escobar-Morreale HF et al. Serum thyroid hormone replacement therapy. Thyroid. 2005.
12. McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Lancet. 2012.
13. Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011.
14. Effraimidis G, Wiersinga WM. Mechanisms in endocrinology: autoimmune thyroid disease. Eur J Endocrinol. 2014.
15. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996.